Get the Stockscreener App
0.508
3.78%
0.0185
After Hours:
.49
-0.018
-3.54%
Cdt Equity Inc stock is traded at $0.508, with a volume of 39,565.
It is up +3.78% in the last 24 hours and down -51.15% over the past month.
CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. The company has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The group is committed to creating shareholder value through licensing, strategic M&A, and positioning the company as a platform for transformative innovation.
See More
Previous Close:
$0.4895
Open:
$0.49
24h Volume:
39,565
Relative Volume:
0.07
Market Cap:
$1.86M
Revenue:
-
Net Income/Loss:
$-20.70M
P/E Ratio:
-0.00191
EPS:
-266.6267
Net Cash Flow:
$-15.13M
1W Performance:
-11.62%
1M Performance:
-51.15%
6M Performance:
-90.75%
1Y Performance:
-99.57%
1-Day Range:
$0.4782
$0.508
1-Week Range:
$0.442
$0.59
52-Week Range:
$0.442
$168.00
Cdt Equity Inc Stock (CDT) Company Profile
Name
Cdt Equity Inc
Sector
Industry
Phone
(646) 491 9132
Address
4851 TAMIAMI TRAIL NORTH, NAPLES
Compare CDT vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDT
Cdt Equity Inc
|
0.508 | 1.67M | 0 | -20.70M | -15.13M | -266.63 |
|
VRTX
Vertex Pharmaceuticals Inc
|
451.59 | 118.41B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
744.12 | 80.02B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.77 | 43.52B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.80 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.29 | 32.13B | 5.36B | 287.73M | 924.18M | 2.5229 |
Cdt Equity Inc Stock (CDT) Latest News
CDT Equity Shareholders Approve Major Capital Restructuring Measures - TipRanks
CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth - Bitget
Cdt Equity stockholders approve all proposals at special meeting, positioning the company for next phase of growth - marketscreener.com
Cdt Equity Stockholders Approve All Proposals At Special Meeting, Positioning The Company For Next Phase Of Growth - TradingView
CDT Equity to map asset portfolio against rare disease database By Investing.com - Investing.com India
CDT Equity to map asset portfolio against rare disease database - Investing.com South Africa
CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence - The Manila Times
AI map of 1,700 rare diseases to steer CDT asset strategy - Stock Titan
CDT Stock Price, Quote & Chart | CDT EQUITY INC (NASDAQ:CDT) - ChartMill
CDT Equity Expands Financing Through New Convertible Note - The Globe and Mail
Cdt Equity lowers floor price to $0.60 in purchase agreement amendment on March 3, 2026SEC filing - marketscreener.com
CDT Equity Lowers Floor Price To $0.60 In Purchase Agreement Amendment On March 3, 2026SEC Filing - TradingView
CDT Equity (CDT) lowers ELOC floor and issues $555,556 secured convertible note - Stock Titan
CDT Equity notes Sarborg patent filing for AI technology By Investing.com - Investing.com Canada
CDT Equity notes Sarborg patent filing for AI technology - Investing.com
CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent - Bitget
CDT Positions for Transformational Growth - Bitget
AI and drug assets: CDT puts $115M into Sarborg to fuel growth - Stock Titan
CDT Equity Inc. announced that it has received $0.555556 million in funding - marketscreener.com
CDT Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
CDTTW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Conduit Pharmaceuticals Expands Stake Using Equity-Funded Acquisition Strategy - TipRanks
CDT Equity to Acquire 20% of Sarborg in Stock, Pre-Funded Warrants and $8 Million Cash - TradingView
CDT Equity (NASDAQ: CDT) uses shares and warrants to acquire 20% of Sarborg - Stock Titan
CDT Equity Inc. Acknowledges Sarborg Limited's Expansion of AI Signature Agent Platform into Bacteria and Agrochemicals - Quiver Quantitative
CDT Equity Notes Sarborg Expansion into Bacteria and Agrochemicals - Bitget
CDT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
CDT Equity (NASDAQ: CDT) director gets stock, 1.94M-share pre-funded warrants - Stock Titan
CDTCDT Equity Latest Stock News & Market Updates - Stock Titan
CDT Equity Inc (CDT) Stock Price, Quote, News & History - Benzinga
CDT Equity acquires 20% stake in Sarborg for $115 million By Investing.com - Investing.com Canada
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
CDT Equity stock tumbles after $115M Sarborg stake deal - Investing.com South Africa
CDT Equity to Acquire 20% Stake in AI Firm Sarborg for $115 Million - marketscreener.com
CDT Equity To Buy 20% Stake In Sarborg To Expand AI Offerings - Nasdaq
CDT Stock Dips as Financial Challenges Mount Amid Market Shifts - timothysykes.com
CDT Acquires Strategic Stake in Sarborg to Transform its AI-Driven Asset Strategy - The Globe and Mail
CDT Equity acquires 20% stake in Sarborg for $115 million - Investing.com
CDT Equity Inc. entered into a strategic transaction to acquire 20% stake in SARBORG Limited for approximately $120 million. - marketscreener.com
Today's SEC FilingsLatest 10-K, 10-Q, 8-K Forms - Stock Titan
CDT Equity (CDT) group reports 9.9% ownership; Ascent holds 204,031 shares - Stock Titan
CDT Environmental Technology Investment (NASDAQ:CDTG) & Enviri (NYSE:NVRI) Head-To-Head Comparison - Defense World
Cdt Equity Inc Stock (CDT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):